🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Edwards Lifesciences Corporation (EW)
NYSE: EW · Real-Time Price · USD
101.85
-2.03 (-1.95%)
At close: Nov 20, 2026, 4:00 PM EST
101.94
+0.09 (0.09%)
After-hours: Nov 20, 2026, 7:59 PM EST

Edwards Lifesciences Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
3,1112,9383,0451,132769862.8
Short-Term Investments
1,5341,288930.7500.5446.3604
Cash & Short-Term Investments
4,6454,2263,9761,6331,2151,467
Cash Growth
20.89%6.30%143.50%34.35%-17.15%4.58%
Accounts Receivable
784.9659.6609.1771.5643582.2
Other Receivables
152.9252.5118.356.656.182.7
Receivables
937.8912.1727.4828.1699.1664.9
Inventory
1,1591,1261,087903.5875.5726.7
Prepaid Expenses
147.2135121128.811085.2
Restricted Cash
0.90.53.23.30.51.5
Other Current Assets
357.5338.8371.2539.2195.4235.6
Total Current Assets
7,2486,7396,2854,0363,0963,181
Property, Plant & Equipment
1,9591,9151,7841,6751,7251,639
Long-Term Investments
262.6278.6307.9583.91,2391,834
Goodwill
1,9521,7691,7771,1451,1641,168
Other Intangible Assets
1,1611,1281,177399.4285.2323.6
Long-Term Deferred Tax Assets
929.41,138992.1749.4484246.7
Other Long-Term Assets
561.9556.5603.1619.2299.1110.8
Total Assets
14,14413,69713,0559,3638,2938,503

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
199.7227.5197.4186.6201.9204.5
Accrued Expenses
1,0751,065790.4667.2593.1643.4
Current Portion of Leases
24.924.523.422.925.525.5
Current Income Taxes Payable
191.4192.5286.652.750.630.6
Current Unearned Revenue
14.927.253.7---
Other Current Liabilities
70.8277153.7266151.3128.3
Total Current Liabilities
1,5771,8141,5051,1951,0221,032
Long-Term Debt
598.8598.3597.7597596.3595.7
Long-Term Leases
80.882.678.965.269.569.1
Long-Term Unearned Revenue
-10.135.1---
Pension & Post-Retirement Benefits
-28.932.136.223.541
Other Long-Term Liabilities
926.6826743.4750774.1928.6
Total Liabilities
3,1833,3602,9922,6442,4862,667

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
662.3658.7654.8650.5646.3642
Additional Paid-In Capital
3,0582,7682,6132,2741,9691,700
Retained Earnings
15,17114,24113,1678,9927,5906,068
Treasury Stock
-7,809-7,092-6,192-5,025-4,144-2,417
Comprehensive Income & Other
-220.2-238.3-244.5-242.8-254.9-157.7
Total Common Equity
10,86110,3389,9986,6505,8075,836
Minority Interest
100.4-64.569.4--
Shareholders' Equity
10,96210,33810,0636,7195,8075,836
Total Liabilities & Equity
14,14413,69713,0559,3638,2938,503

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
704.5705.4700685.1691.3690.3
Net Cash (Debt)
3,9883,5283,281947.7524776.5
Net Cash Growth
26.70%7.51%246.25%80.86%-32.52%9.72%
Net Cash Per Share
6.886.025.481.560.841.23
Filing Date Shares Outstanding
575580.8587.9601.3608.31623.21
Total Common Shares Outstanding
575.6580.7588.6601.1608.3624.1
Working Capital
5,6714,9254,7802,8402,0732,148
Book Value Per Share
18.8717.8016.9911.069.559.35
Tangible Book Value
7,7487,4417,0455,1064,3574,344
Tangible Book Value Per Share
13.4612.8111.978.497.166.96
Land
-152.4123.9112.4116.3116.5
Buildings
-1,3931,3401,1891,1891,010
Machinery
-739.8689.4618.6735652.6
Construction In Progress
-301.2244292.5255.2333.8
SEC Filings: 10-K · 10-Q